Niranjan Y Sardesai

8PUBLICATIONS
48CO-AUTHORS
NanomedicineMolecular targetsTumour immunologyInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

|Apr 07, 2024
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.

Mark Yarchoan, Edward J Gane, Thomas U Marron

|Jan 26, 2019
A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge.

Elizabeth K Duperret, Alfredo Perales-Puchalt, Regina Stoltz

|Jun 26, 2018
Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.

Xintao Hu, Zhongyan Lu, Antonio Valentin

|May 26, 2018
Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques.

Shakti Singh, Eric G Ramírez-Salazar, Rami Doueiri

|Oct 19, 2017
A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever.

Kathleen A Cashman, Eric R Wilkinson, Carl I Shaia

Pageof 2

Frequent Collaborators

2 joint publications

Elizabeth A R Garfinkle

2 joint publications

Obi L Griffith

2 joint publications

Tanner M Johanns

2 joint publications

Margherita Rosati